SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 12, 2026

IMNM

Immunome Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed3mo ago
Insider cluster: 2 insiders, $2.5M total
Actionable Insight • Neutral

The insider sales are small relative to market cap and involve a director and a CBO, not the CEO/CFO. Monitor for any upcoming material news (e.g., clinical data, partnership) that could explain the timing, but no immediate action warranted.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$26.42
T+0 close · Aug 12, 2026 · via day close
Latest settled
−29.18%
T+60 · $18.71
Vs SPY
−23.71%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 13 $26.42entry
  2. T+1 · 3mo ago +2.95%α +3.15% · $27.20
  3. T+5 · 3mo ago +6.28%α +8.25% · $28.08
  4. T+20 · 2mo ago −6.62%α −4.88% · $24.67
  5. T+60 · 11d ago −29.18%α −23.71% · $18.71

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at Immunome sold a total of $2.54M in shares over a week, led by the Chief Business Officer's $2.27M sale. Director Isaac Barchas also sold $264K. While the dollar amount is modest relative to the $3.0B market cap (~0.08%), the cluster includes a C-suite officer selling a large block, which warrants attention.

Key Financial Metrics

Direction
selling
Total Value
$2.5M
Insiders
2

Key Facts

  • Chief Business Officer Horn Kinney sold 90.6K shares for $2.27M on 2026-08-04.
  • Director Isaac Barchas sold 10.1K shares for $264K on 2026-08-10.
  • Total insider sales in the cluster: $2.54M, or ~0.08% of market cap.
  • The cluster includes a C-suite officer, but insider sales are weak predictors per academic literature.

Financial Impact

Total insider sales of $2.54M represent ~0.08% of the $3.0B market cap, a trivial amount.

dilution

Risk Factors

  • Insider sales could precede negative news, though the dollar amount is small.
  • Stock has been volatile with mixed prior signal outcomes; avoid over-interpreting this cluster.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IMNM-1786572087189

Track record

20 reports on IMNM

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +26.53% at T+60 after the May 28, 2026 report. 6 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $18.39 Now $17.61 −4.24% settles Feb 12
  2. Nov 9, 20267d ago S-3ASR Neutral 3/10 Entry $18.65 Now $17.61 −5.58% settles Feb 8
  3. Nov 9, 20267d ago S-3ASR Neutral 3/10 Entry $18.65 Now $17.61 −5.58% settles Feb 8
  4. Nov 9, 20267d ago 8-K Bearish 5/10 Entry $18.65 Now $17.61 +5.58% settles Feb 8
  5. Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $18.21 Now $17.61 −3.29% settles Jan 28
  6. Oct 16, 20264w ago ANALYST-UPGRADE Bullish 4/10 Entry $16.47 Now $17.61 +6.92% settles Jan 13
  7. Oct 5, 20266w ago 8-K Bullish 6/10 Entry $21.17 Now $17.61 −16.82% settles Dec 30
  8. Oct 1, 20266w ago ANALYST-UPGRADE Bearish 4/10 Entry $20.89 Now $17.61 +15.70% settles Dec 28
  9. Sep 21, 20268w ago ANALYST-UPGRADE Bullish 4/10 Entry $25.07 Now $17.61 −29.76% settles Dec 15
  10. Aug 12, 202613w ago Insider Cluster Neutral 4/10 Viewing Entry $26.42 to $18.71 Now $17.61 −33.35% ▼ −29.18% −23.71% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 6h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 12, 2026